AntibioticDB

Highest development stage: Preclinical

Development active

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Moderately active against a wide range of Gram-negative bacteria and highly active against Gram-positive bacteria.

GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11022

Source: https://www.sciencedirect.com/science/article/pii/S0040403900854398

Citation (1): https://www.jstage.jst.go.jp/article/antibiotics1968/42/1/42_1_84/_article

Patents: WO2019034701 A1; WO2019034700 A1; WO2019034702 A1

Compound/Drug Structure: https://pubchem.ncbi.nlm.nih.gov/compound/9881937

Lactivicin

Cell-wall synthesis inhibitor (non-beta-lactam antibiotic)

Applied Microbiology Laboratories, Central Research Division, Takeda Chemical Industries, Ltd., Yodogawa-ku, Osaka 532, Japan

1986